Why the study?
Several medication adherence patient-reported outcome measures exist for patients with CVD, but little evidence identifies the most suitable measure for clinical practice or research.
What are the most suitable medication adherence patient-reported outcome measures (MA-PROMs) for use in patients with cardiovascular disease?
Population
84 studies evaluating 40 MA-PROMs in patients with CVD
Design
COSMIN systematic review
Authors
Loading...
ARMS and ARMS-7 emerge as preferred MA-PROMs for CVD; extends COSMIN synthesis with actionable selection guidance for clinicians and researchers.
What are the most suitable medication adherence patient-reported outcome measures (MA-PROMs) for use in patients with cardiovascular disease?
Based on COSMIN guidelines, the ARMS and ARMS-7 scales are the most suitable and comprehensive patient-reported outcome measures for assessing medication adherence in patients with cardiovascular disease.
Tegegn et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: